Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia

Leukemia and Lymphoma

Volumn 47, Issue 5, 2006, Pages 897-906

  Sonneck, Karoline ^a   Florian, Stefan ^a   Böhm, Alexandra ^a   Krauth, Maria Theresa ^a   Kondo, Rudin ^a   Hauswirth, Alexander W ^a   Gleixner, Karoline V ^a   Aichberger, Karl J ^a   Derdak, Sophia ^b   Pickl, Winfried F ^b   Sperr, Wolfgang R ^a   Schwartz, Lawrence B ^c   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AML; GM CSF; PAR 2; Paracrine factors; SCF; Tryptase

Indexed keywords

CELL ENZYME; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 2; RECOMBINANT ENZYME; STEM CELL FACTOR; THYMIDINE; TRITIUM; TRYPTASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW CELL; BONE MARROW CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SECRETION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; LEUKEMIA CELL; LUNG FIBROBLAST; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM;

ACUTE DISEASE; ADULT; AGED; BLAST CRISIS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PARACRINE COMMUNICATION; SERINE ENDOPEPTIDASES; TRITIUM; TRYPTASES;

EID: 33744932203     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500513652     Document Type: Article

References (49)

1. Vellenga, E and Griffin, J. (1987) The biology of acute myeloid leukemia Semin Oncol, 14, pp. 365-371.
2. Strout, M and Marcucci, G and Caligiuri, M and Bloomfield, C. (1999) Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: Biology and clinical implications Ann Hematol, 78, pp. 251-264.
3. Kelly, L and Gilliland, D. (2002) Genetics of myeloid leukemias Annu Rev Genomics Hum Genet, 3, pp. 179-198.
4. Pallis, M and Turzanski, J and Higashi, Y and Russell, N. (2002) P-glycoprotein in acute myeloid leukaemia: Therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype Leuk Lymphoma, 43, pp. 1221-1228.
5. Bendall, L and Daniel, A and Kortlepel, K and Gottlieb, D. (1994) Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells Exp Hematol, 22, pp. 1252-1260.
6. Albitar, M. (2001) Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome Acta Haematol, 106, pp. 170-176.
7. Bradstock, K and Gottlieb, D. (1995) Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease Leuk Lymphoma, 18, pp. 1-16.
8. Young, D and Griffin, J. (1986) Autocrine secretion of GM-CSF in acute myeloblastic leukemia Blood, 68, pp. 1178-1181.
9. Stocking, C and Loliger, C and Kawai, M and Suciu, S and Gough, N and Ostertag, W. (1988) Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants Cell, 53, pp. 869-879.
10. Bieker, R and Padro, T and Kramer, J and Steins, M and Kessler, T and Retzlaff, S and (2003) Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia Cancer Res, 63, pp. 7241-7246.
11. Wakabayashi, M and Miwa, H and Shikami, M and Hiramatsu, A and Ikai, T and Tajima, E and (2004) Autocrine pathway of angiopoietins-Tie2 system in AML cells: Association with phosphatidyl-inositol 3 kinase Hematol J, 5, pp. 353-360.
12. Estrov, Z and Talpaz, M. (1997) Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell death Leuk Lymphoma, 24, pp. 379-391.
13. Gattei, V and Degan, M and Rossi, F and de Iuliis, A and Mazzocco, F and Serraino, D and (1999) CD30 ligand (CD30L)-expressing acute myeloid leukemias: A new model of paracrine interactions for the regulation of blast cells proliferation Leuk Lymphoma, 35, pp. 21-35.
14. Schuringa, J and Wierenga, A and Kruijer, W and Vellenga, E. (2000) Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 Blood, 95, pp. 3765-3770.
15. Bruserud, O and Nesthus, I and Buhring, H and Pawelec, G. (1995) Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro Leuk Res, 19, pp. 15-22.
16. Griffin, J and Rambaldi, A and Vellenga, E and Young, D and Ostapovicz, D and Cannistra, S. (1987) Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors Blood, 70, pp. 1218-1221.
17. Bradbury, D and Rogers, S and Reilly, I and Kozlowski, R and Russell, N. (1992) Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells-studies using purified CD34-positive cells Leukemia, 6, pp. 562-566.
18. Sperr, W and Jordan, J and Baghestanian, M and Kiener, H and Samorapoompichit, P and Semper, H and (2001) Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia Blood, 98, pp. 2200-2209.
19. Sperr, W and Horny, H and Lechner, K and Valent, P. (2000) Clinical and biologic diversity of leukemias occurring in patients with mastocytosis Leuk Lymphoma, 37, pp. 473-486.
20. Valent, P and Sperr, W and Samorapoompichit, P and Geissler, K and Lechner, K and Horny, H and (2001) Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis Leuk Res, 25, pp. 595-602.
21. Sperr, W and Hauswirth, A and Valent, P. (2002) Tryptase a novel biochemical marker of acute myeloid leukemia Leuk Lymphoma, 43, pp. 2257-2261.
22. Schwartz, L and Lewis, R and Austen, K. (1981) Tryptase from human pulmonary mast cells. Purification and characterization J Biol Chem, 256, pp. 11939-11943.
23. Schwartz, L and Foley, J and Austen, K and Soter, N and Shepard, R and Murphy, G. (1985) Localization of tryptase to human cutaneous mast cells and keratinocytes by immunofluorescence and immunoperoxidase cytochemistry with monoclonal antitryptase antibody J Allergy Clin Immunol, 76, pp. 182-188.
24. Irani, A and Schechter, N and Craig, S and DeBlois, G and Schwartz, L. (1986) Two types of human mast cells that have distinct neutral protease compositions Proc Natl Acad Sci USA, 83, pp. 4464-4468.
25. Jogie-Brahim, S and Min, H and Fukuoka, Y and Xia, H and Schwartz, L. (2004) Expression of alpha-tryptase and beta-tryptase by human basophils J Allergy Clin Immunol, 113, pp. 1086-1092.
26. Schwartz, L and Sakai, K and Bradford, T and Ren, S and Zweiman, B and Worobec, A and (1995) The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis J Clin Invest, 96, pp. 2702-2710.
27. Sakai, K and Ren, S and Schwartz, L. (1996) A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I J Clin Invest, 97, pp. 988- 995.
28. Kanthawatana, S and Carias, K and Arnaout, R and Hu, J and Irani, A and Schwartz, L. (1999) The potential clinical utility of serum alpha-protryptase levels J Allergy Clin Immunol, 103, pp. 1092-1099.
29. Schwartz, L and Min, H and Ren, S and Xia, H and Hu, J and Zhao, W and (2003) Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells J Immunol, 170, pp. 5667-5673.
30. Ruoss, S and Hartmann, T and Caughey, G. (1991) Mast cell tryptase is a mitogen for cultured fibroblasts J Clin Invest, 88, pp. 493-499.
31. Hartmann, T and Ruoss, S and Raymond, W and Seuwen, K and Caughey, G. (1992) Human tryptase as a potent, cell-specific mitogen: Role of signaling pathways in synergistic responses Am J Physiol, 262, pp. 528-534.
32. Abe, M and Kurosawa, M and Ishikawa, O and Miyachi, Y and Kido, H. (1998) Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production Clin Exp Allergy, 28, pp. 1509-1517.
33. Frungieri, M and Albrecht, M and Raemsch, R and Mayerhofer, A. (2005) The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2) Cell Signal, 17, pp. 525-533.
34. Schwartz, L and Bradford, T and Rouse, C and Irani, A and Rasp, G and Van der Zwan, J and (1994) Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis J Clin Immunol, 14, pp. 190-204.
35. Schwartz, L and Bradford, T and Lee, D and Chlebowski, J. (1990) Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase J Immunol, 144, pp. 2304-2311.
36. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br J Haematol, 33, pp. 451-458.
37. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group Ann Intern Med, 103, pp. 620-625.
38. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group Ann Intern Med, 103, pp. 460-462.
39. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol, 78, pp. 325-329.
40. Mayerhofer, M and Florian, S and Krauth, M and Aichberger, K and Bilban, M and Marculescu, R and (2004) Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia Cancer Res, 64, pp. 3148-3154.
41. Krauth, M and Simonitsch, I and Aichberger, K and Mayerhofer, M and Sperr, W and Sillaber, C and (2004) Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease Am J Clin Pathol, 121, pp. 473-481.
42. Florian, S and Sonneck, K and Hauswirth, A and Krauth, M and Schernthaner, G and Sperr, W and (2006) Detection of molecular targets on the surface of CD34+/CD38- stem cells in various myeloid malignancies Leuk Lymphoma, 47, pp. 207-222.
43. Kaddu, S and Zenahlik, P and Beham-Schmid, C and Kerl, H and Cerroni, L. (1999) Specific cutaneous infiltrates in patients with myelogenous leukemia: A clinicopathologic study of 26 patients with assessment of diagnostic criteria J Am Acad Dermatol, 40, pp. 966-978.
44. Lee, K and Lee, J and Kim, S and Lee, J and Kim, S and Kim, W. (2000) High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation Bone Marrow Transplant, 26, pp. 147-152.
45. Dery, O and Corvera, C and Steinhoff, M and Bunnett, N. (1998) Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases Am J Physiol, 274, pp. 1429-1452.
46. Coelho, A and Ossovskaya, V and Bunnett, N. (2003) Proteinase-activated receptor-2: Physiological and pathophysiological roles Curr Med Chem Cardiovasc Hematol Agents, 1, pp. 61-72.
47. O'Brien, P and Molino, M and Kahn, M and Brass, L. (2001) Protease activated receptors: Theme and variations Oncogene, 20, pp. 1570-1581.
48. Levi-Schaffer, F and Piliponsky, A. (2003) Tryptase, a novel link between allergic inflammation and fibrosis Trends Immunol, 24, pp. 158-161.
49. Johansson, U and Lawson, C and Dabare, M and Syndercombe-Court, D and Newland, A and Howells, G and (2005) Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1β J Leukoc Biol, 78, pp. 967-975.